Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
van der Goes MC, Jacobs JW, Jurgens MS, Bakker MF, van der Veen MJ, van der Werf JH, Welsing PM, Bijlsma JW. van der Goes MC, et al. Among authors: welsing pm. Osteoporos Int. 2013 Apr;24(4):1429-36. doi: 10.1007/s00198-012-2073-z. Epub 2012 Aug 2. Osteoporos Int. 2013. PMID: 23011680 Free PMC article. Clinical Trial.
Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study.
Bakker MF, Jacobs JW, Welsing PM, van der Werf JH, Linn-Rasker SP, van der Veen MJ, Lafeber FP, Bijlsma JW; Utrecht Arthritis Cohort Study Group. Bakker MF, et al. Among authors: welsing pm. Ann Rheum Dis. 2010 Oct;69(10):1849-52. doi: 10.1136/ard.2009.124065. Epub 2010 May 28. Ann Rheum Dis. 2010. PMID: 20511610 Clinical Trial.
Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study.
Bakker MF, Jacobs JW, Welsing PM, Vreugdenhil SA, van Booma-Frankfort C, Linn-Rasker SP, Ton E, Lafeber FP, Bijlsma JW; Utrecht Arthritis Cohort Study Group. Bakker MF, et al. Among authors: welsing pm. Ann Rheum Dis. 2011 Jun;70(6):1099-103. doi: 10.1136/ard.2010.137943. Epub 2011 Mar 15. Ann Rheum Dis. 2011. PMID: 21406458 Clinical Trial.
The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial.
Bakker MF, Verstappen SM, Welsing PM, Jacobs JW, Jahangier ZN, van der Veen MJ, Bijlsma JW, Lafeber FP; Utrecht Arthritis Cohort study group. Bakker MF, et al. Among authors: welsing pm. Arthritis Res Ther. 2011 May 8;13(3):R70. doi: 10.1186/ar3331. Arthritis Res Ther. 2011. PMID: 21539729 Free PMC article. Clinical Trial.
Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids.
Hoes JN, van der Goes MC, van Raalte DH, van der Zijl NJ, den Uyl D, Lems WF, Lafeber FP, Jacobs JW, Welsing PM, Diamant M, Bijlsma JW. Hoes JN, et al. Among authors: welsing pm. Ann Rheum Dis. 2011 Nov;70(11):1887-94. doi: 10.1136/ard.2011.151464. Epub 2011 Sep 10. Ann Rheum Dis. 2011. PMID: 21908880
179 results